SGRY - Surgery Partners Non-GAAP EPS of $0.27 beats by $0.09 revenue of $707.1M beats by $18.45M
- Surgery Partners press release ( NASDAQ: SGRY ): Q4 Non-GAAP EPS of $0.27 beats by $0.09 .
- Revenue of $707.1M (+15.9% Y/Y) beats by $18.45M .
- Adjusted EBITDA increased 5.6% to $120.8 million in the fourth quarter 2022 versus 2021
- 2023 Outlook:
- The Company projects 2023 revenues to be greater than $2.75 billion vs consensus of $2.81B, and projects 2023 Adjusted EBITDA to be greater than $425 million.
For further details see:
Surgery Partners Non-GAAP EPS of $0.27 beats by $0.09, revenue of $707.1M beats by $18.45M